EUVIMEDEUVIMED entdecken
VergleichsstudieLeitlinieOpen Access · CC BY 4.0

Clinical Guideline for Preimplantation Genetic Testing in Inherited Cardiac Diseases

Job A J Verdonschot iD, Debby M E I Hellebrekers iD, Vanessa P M van Empel, Malou Heijligers iD, Sonja de Munnik iD, Edith Coonen iD, Jos C M F Dreesen, Arthur van den Wijngaard, Han G Brunner iD, Masoud Zamani Esteki iD, Stephane R B Heymans iD, Christine E M de Die-Smulders iD und 1 weitere

Circulation: Genomic and Precision Medicine · 2024

DOI: 10.1161/circgen.123.004416 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Circulation: Genomic and Precision Medicine, 2024. Verfasst von Job A J Verdonschot und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Genetics, Maastricht University Medical Center, the Netherlands (J.A.J.V., D.M.E.I.H., M.H., S.d.M., E.C., J.C.M.F.D., A.v.d.W…. Hauptthemen laut MEDLINE: Genetic Testing, Heart Diseases, Preimplantation Diagnosis, Clinical Decision-Making. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Preimplantation genetic testing (PGT) is a reproductive technology that selects embryos without (familial) genetic variants. PGT has been applied in inherited cardiac disease and is included in the latest American Heart Association/American College of Cardiology guidelines. However, guidelines selecting eligible couples who will have the strongest risk reduction most from PGT are lacking. We developed an objective decision model to select eligibility for PGT and compared its results with those from a multidisciplinary team. METHODS: All couples with an inherited cardiac disease referred to the national PGT center were included. A multidisciplinary team approved or rejected the indication based on clinical and genetic information. We developed a decision model based on published risk prediction models and literature, to evaluate the severity of the cardiac phenotype and the penetrance of the familial variant in referred patients. The outcomes of the model and the multidisciplinary team were compared in a blinded fashion. RESULTS: Eighty-three couples were referred for PGT (1997–2022), comprising 19 different genes for 8 different inherited cardiac diseases (cardiomyopathies and arrhythmias). Using our model and proposed cutoff values, a definitive decision was reached for 76 (92%) couples, aligning with 95% of the multidisciplinary team decisions. In a prospective cohort of 11 couples, we showed the clinical applicability of the model to select couples most eligible for PGT. CONCLUSIONS: The number of PGT requests for inherited cardiac diseases increases rapidly, without the availability of specific guidelines. We propose a 2-step decision model that helps select couples with the highest risk reduction for cardiac disease in their offspring after PGT.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Genetic TestingHeart DiseasesPreimplantation DiagnosisClinical Decision-MakingReferral and ConsultationGenetic Diseases, InbornFemaleHumansMaleArrhythmias, CardiacCardiomyopathiesRisk ManagementHeterozygoteProspective StudiesFamily CharacteristicsPregnancy

Stichwörter der Autor:innen

American Heart AssociationBrugada syndromecardiomyopathiesheart diseaseheart transplantation

Autor:innen und Institutionen

  • Department of Clinical Genetics, Maastricht University Medical Center, the Netherlands (J.A.J.V., D.M.E.I.H., M.H., S.d.M., E.C., J.C.M.F.D., A.v.d.W., H.G.B., M.Z.E., C.E.M.d.D.-S., A.D.C.P.).
  • Department of Cardiology, Maastricht University, Cardiovascular Research Institute Maastricht, the Netherlands (J.A.J.V., V.P.M.v.E., S.R.B.H.).
  • European Reference Network for Rare, Low Prevalence and Complex Diseases of the Heart (ERN GUARD-Heart) (J.A.J.V., D.M.E.I.H., V.P.M.v.E., S.R.B.H.).
  • Department of Human Genetics, Donders Institute for Brain, Cognition and Behavior, Radboud University Medical Center, Nijmegen, the Netherlands (S.d.M., H.G.B.).
  • GROW School for Oncology and Reproduction, Maastricht University, the Netherlands (E.C., H.G.B., M.Z.E., C.E.M.d.D.-S., A.D.C.P.).
  • Department of Cardiovascular Sciences, Centre for Molecular and Vascular Biology, KU Leuven, Belgium (S.R.B.H.).

ORCID-Profile: Job A J Verdonschot, Debby M E I Hellebrekers, Malou Heijligers, Sonja de Munnik, Edith Coonen, Han G Brunner, Masoud Zamani Esteki, Stephane R B Heymans, Christine E M de Die-Smulders, Aimée D C Paulussen

Zitieren

APA

Verdonschot, J. A. J., Hellebrekers, D. M. E. I., van Empel, V. P. M., Heijligers, M., de Munnik, S., Coonen, E., Dreesen, J. C. M. F., van den Wijngaard, A., Brunner, H. G., Zamani Esteki, M., Heymans, S. R. B., de Die-Smulders, C. E. M., & Paulussen, A. D. C. (2024). Clinical Guideline for Preimplantation Genetic Testing in Inherited Cardiac Diseases. Circulation: Genomic and Precision Medicine. https://doi.org/10.1161/circgen.123.004416

Vancouver

Verdonschot JAJ, Hellebrekers DMEI, van Empel VPM, Heijligers M, de Munnik S, Coonen E, et al. Clinical Guideline for Preimplantation Genetic Testing in Inherited Cardiac Diseases. Circulation: Genomic and Precision Medicine. 2024. doi:10.1161/circgen.123.004416

BibTeX
@article{Verdonschot2024,
  author = {Verdonschot, Job A J and Hellebrekers, Debby M E I and van Empel, Vanessa P M and Heijligers, Malou and de Munnik, Sonja and Coonen, Edith and Dreesen, Jos C M F and van den Wijngaard, Arthur and Brunner, Han G and Zamani Esteki, Masoud and Heymans, Stephane R B and de Die-Smulders, Christine E M and Paulussen, Aimée D C},
  title = {Clinical Guideline for Preimplantation Genetic Testing in Inherited Cardiac Diseases},
  journal = {Circulation: Genomic and Precision Medicine},
  year = {2024},
  doi = {10.1161/circgen.123.004416}
}
Kostenlos starten →